Hosted on MSN1mon
Novartis to buy Anthos Therapeutics for up to $3.1BNovartis is especially well positioned to advance abelacimab’s clinical development and bring this innovative product to healthcare providers and patients," commented Bill Meury, CEO of Anthos.
After all the activity, Business Insider caught up with Allergan's newly promoted Chief Commercial Officer Bill Meury and Herm Cukier, Senior Vice President of Women's Healthcare, to hear what's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results